Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma.
Jin-Tao HuangBin-Yan ZhongNan JiangWan-Ci LiShuai ZhangYu YinJun YangJian ShenWan-Sheng WangXiao-Li ZhuPublished in: Journal of hepatocellular carcinoma (2022)
TACE combined with ICIs plus TKIs significantly improved OS, ORR, and DCR and showed a relatively longer PFS trend over ICIs combined with TKIs for advanced HCC.
Keyphrases